IOL Chemicals and Pharmaceuticals Limited
₹195.09▲ +0.01 (+0.01%)
IOLCP·NSE·Healthcare
Market Cap
5719.38 Cr
PE Ratio
41.60
Volume
16,77,727
Day High - Low
198.00 - 191.00
52W High-Low
224.00 - 67.19
₹195.09▲ +0.01 (+0.01%)
Market Cap5719.38 Cr
PE Ratio41.60
Volume16,77,727
Day High - Low198.00 - 191.00
52W High-Low224.00 - 67.19
IOL Chemicals and Pharmaceuticals Limited (IOLCP): company summary
The company's annual revenue rose 11.5% to ₹2,319 crore, while net profit surged 36.3% to ₹138 crore.
IOL Chemicals and Pharmaceuticals Limited (IOLCP) is a small-cap Healthcare company valued at ₹5,719 crore operating in Pharmaceuticals on the NSE and BSE.
- Recent price move
- IOL Chemicals and Pharmaceuticals Limited last traded at ₹195.09, modestly up 0.01% on the day.
- Recent developments
- On 2026-06-30, the company reported a significant increase in both revenue and net profit for the latest quarter, with revenue and profit rising sharply compared to the same period a year ago. Promoter holding increased by 4.80 percentage points to 62.28%, while foreign institutional holding rose by 3.15 percentage points to 4.87%.
- Financial performance
- The company's annual revenue rose 11.5% to ₹2,319 crore, while net profit surged 36.3% to ₹138 crore. The latest quarter saw revenue jump 37.0% to ₹756 crore and net profit soar 89.4% to ₹64 crore, outpacing the same quarter a year earlier. The net profit margin widened to 5.9% from 4.9% in the prior year, reflecting improved profitability.
- Valuation multiples
- The stock trades at 41.6 times earnings, a premium to the Healthcare median of 32.0, 3.42 times book value. It yields 0.5%.
- Things to watch
- The company's profit growth has slowed over the past five years, with a -20.9% CAGR in net profit. The stock is currently 4.4% below its 52-week high, and the return on equity remains low at 7.7%. The company's profit growth has also been negative over the past three years, with a -0.6% CAGR.
- Where it stands
- The company has delivered strong revenue and net profit growth in the latest quarter, with both metrics rising sharply compared to the same period a year ago. The net profit margin has also improved, but the company's long-term profit growth has been weak. The stock is currently trading below its 52-week high, and the company's return on equity remains low.
Summarised by DocStoX's model on 2026-10-03 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
DocStoX Score
3.4/10
Poor
Fair Value
Sign in to see
ROE
7.65%
Weak
P/E
41.60x
Expensive
Debt / Equity
0.08
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Mixed
Price performance
Day₹191.00
₹198.00
52W₹67.19
₹224.00
DocStoX take
Supported by risk (8.2) and momentum (7.5), but held back by growth (0.5). Risk looks strong at 8.2, but that is offset by valuation at 0.5 and growth at 0.5. We are calling it Mixed rather than resolving the conflict for you.
DocStoX score
Low confidence3.4
/10
Poor
Quality
Modest
ROE 7.7%
Valuation
Expensive
P/E 41.6×
Growth
Flat
Revenue +3.4% 5Y CAGR
Risk
Low risk
D/E 0.08
Momentum
Strong
82% of 52-week range
At a glance
Market Cap
₹5,719 Cr
52W High / Low
₹224 / ₹67
Dividend Yield
0.51%
Promoter Holding
62.28%
EPS (TTM)
₹4.69
Book Value
₹61.27
Key highlights
- Low leverage — D/E 0.08
- Profitable in all of the last 5 years
- Profit shrinking 21% a year
- Valuation is weak (0.5/10)
2 Positives4 Watchouts
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare stocks · Pharmaceuticals
Explore IOL Chemicals and Pharmaceuticals Limited’s valuation
Free deep-dive tools · no sign-up
Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.
IOL Chemicals and Pharmaceuticals Limited peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
Sun Pharmaceutical Industries LimitedDivi's Laboratories LimitedTorrent Pharmaceuticals LimitedApollo Hospitals Enterprise LimitedZydus Lifesciences LimitedLaurus Labs LimitedCipla LimitedDr. Reddy's Laboratories LimitedAurobindo Pharma LimitedMankind Pharma LimitedLupin LimitedManipal Health Enterprises Limited
Compare IOL Chemicals and Pharmaceuticals Limited with peers
IOL Chemicals and Pharmaceuticals Limited vs Sun Pharmaceutical Industries LimitedIOL Chemicals and Pharmaceuticals Limited vs Divi's Laboratories LimitedIOL Chemicals and Pharmaceuticals Limited vs Torrent Pharmaceuticals LimitedIOL Chemicals and Pharmaceuticals Limited vs Apollo Hospitals Enterprise LimitedIOL Chemicals and Pharmaceuticals Limited vs Zydus Lifesciences LimitedIOL Chemicals and Pharmaceuticals Limited vs Laurus Labs Limited
Related tools & concepts
Value IOL Chemicals and Pharmaceuticals Limited with the ratios and calculators DocStoX uses in its analysis.
P/E RatioPrice to earningsReturn on Equity (ROE)ProfitabilityROCECapital efficiencyDebt to EquityLeverageP/B RatioPrice to bookNet Profit MarginBottom-line efficiencyDCF / Intrinsic ValueEstimate fair valueCAGR CalculatorAnnualised returnDividend YieldIncome on pricePosition SizeRisk-based sizingBrokerage CalculatorCharges on a tradeSIP CalculatorSystematic investing